Stoush over ‘archaic pricing’ threatens access to key drugs
SYDNEY: Thousands of patients with multiple sclerosis face the prospect of losing publicly funded access
SYDNEY: Thousands of patients with multiple sclerosis face the prospect of losing publicly funded access